Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
This study is currently recruiting participants.
Verified May 2012 by Lanx, Inc.
Sponsor:
Lanx, Inc.
Information provided by (Responsible Party):
Lanx, Inc.
ClinicalTrials.gov Identifier:
NCT01549366
First received: February 29, 2012
Last updated: May 11, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this clinical investigation is to evaluate the Aspen™ device compared to pedicle screw instrumentation for posterior fixation in the treatment of patients with degenerative disc disease and/or spondylolisthesis. The Aspen™ device will be compared to pedicle screw instrumentation in Oswestry Disability Index (ODI) improvement and success of fusion.
| Condition | Intervention | Phase |
|---|---|---|
|
Degenerative Disc Disease (DDD) |
Device: Aspen Spinous Process Fixation Device Device: Pedicle Screw Fixation |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF) |
Further study details as provided by Lanx, Inc.:
Primary Outcome Measures:
- Absolute change in Oswestry Disability Index (ODI) [ Time Frame: baseline to 12 months post-operative ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Fusion success [ Time Frame: 12 Months post-operative ] [ Designated as safety issue: No ]
- Neurological status [ Time Frame: Baseline, 6 weeks, 3 months, 6 months, 12 months, & 24 months ] [ Designated as safety issue: No ]
- Change in EQ-5D-3L [ Time Frame: Baseline, 6 weeks, 3 months, 6 months, 12 months, & 24 months ] [ Designated as safety issue: No ]
- Change in SF-36 [ Time Frame: Baseline, 12 months & 24 months ] [ Designated as safety issue: No ]
- Change in Visual Analogue Scale (VAS) (pain) [ Time Frame: Baseline, 6 weeks, 3 months, 6 months, 12 months, & 24 months ] [ Designated as safety issue: No ]
- Change in Zurich Claudication Questionnaire [ Time Frame: Baseline, 12 months & 24 months ] [ Designated as safety issue: No ]
- Pain medication usage [ Time Frame: Baseline, surgery, 6 weeks, 3 months, 6 months, 12 months, & 24 months ] [ Designated as safety issue: No ]
- Operative parameters (estimate blood loss, fluor time, length of hospital stay) [ Designated as safety issue: No ]
| Estimated Enrollment: | 144 |
| Study Start Date: | February 2012 |
| Estimated Study Completion Date: | May 2015 |
| Estimated Primary Completion Date: | May 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Aspen Spinous Process Fixation Device
The Aspen device provides supplemental posterior fixation for fusion
|
Device: Aspen Spinous Process Fixation Device
The Aspen device will be placed as posterior fixation to Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
|
|
Active Comparator: Pedicle Screws
Pedicle Screws provide supplemental posterior fixation for fusion
|
Device: Pedicle Screw Fixation
Pedicle Screws will be placed as posterior fixation to Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
|
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Age between 18 and 75 years
- Scheduled for an elective single-level circumferential lumbar fusion by means of supplemental posterior fusion with fixation (allowing for the placement of ASPEN or pedicle screws) for an anterior or lateral interbody fusion
- Diagnosis of primary symptomatic Degenerative Disc Disease (DDD) and/or spondylolisthesis confirmed with appropriate imaging studies and/or positive lumbar discography
- Oswestry Disability Index (ODI) v2.1 score > 30%
- Failed at least 3 months of conservative care (non-surgical) OR has clinical signs of neurological deterioration
- Signed Informed Consent Form
Exclusion Criteria:
- Previous fusion at the operative level
- Spondylolisthesis Grade 3 or more
- Lytic spondylolisthesis
- Incompetent or missing posterior arch at the affected level (e.g. complete laminectomy, pars defect)
- Requires complete laminectomy at level of surgery
- Facet joints at implant level are absent or fractured
- Vertebral body compromise or acute fracture at implant level
- Body mass Index (BMI) ≥ 35
- Known allergy to titanium
- Osteoporosis: Simple Calculated Osteoporosis Risk Estimation (S.C.O.R.E.) > 6 AND Dual-energy X-ray absorptiometry (DEXA) T-score < -2.5
- Paget's disease, osteomalacia, or any other metabolic bone disease
- Use of medications or any drug known to potentially interfere with bone/soft tissue healing (e.g. chronic systemic steroids)
- Planned use of additional segmental fixation (eg. facet screws)
- Planned use of Bone Morphogenetic Protein (BMP) for posterolateral fusion*
- Unlikely to comply with the follow-up evaluation schedule
- In the opinion of the Investigator, Subject has history of chemical substance dependency or significant psychosocial disturbance that may impact the outcome or study participation
- Active participation in a clinical trial of another drug or device
- Active systemic infection or any other health condition that would preclude surgery
- History of invasive malignancy, except if the subject has received treatment and displayed no clinical signs and symptoms for at least five years
- Subject is a prisoner
- Pregnant or planning to become pregnant during the length of study participation
- Involvement in active litigation related to back problems at the time of screening
- Direct involvement in the execution of this protocol
- Pre-existing conditions that could interfere with the evaluation of outcome measures (e.g. musculoskeletal, neuromuscular, etc.)
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01549366
Contacts
| Contact: Pam Snyder | 303-501-8394 | pam.snyder@lanx.com |
Locations
| United States, California | |
| University of California, San Diego | Not yet recruiting |
| San Diego, California, United States | |
| United States, Colorado | |
| University of Colorado Denver | Not yet recruiting |
| Aurora, Colorado, United States | |
| United States, Illinois | |
| Rush University Neurosurgery | Recruiting |
| Chicago, Illinois, United States | |
| Midwest Orthopaedics at Rush Medical Center | Recruiting |
| Chicago, Illinois, United States | |
| United States, Massachusetts | |
| The Boston Spine Group | Recruiting |
| Newton, Massachusetts, United States | |
| United States, New York | |
| Buffalo Spine Surgery | Recruiting |
| Lockport, New York, United States | |
| United States, Texas | |
| Spine Team Texas | Recruiting |
| Southlake, Texas, United States | |
Sponsors and Collaborators
Lanx, Inc.
Investigators
| Principal Investigator: | Patel | University of Colorado, Denver |
| Principal Investigator: | Taylor | University of California, San Diego |
More Information
No publications provided
| Responsible Party: | Lanx, Inc. |
| ClinicalTrials.gov Identifier: | NCT01549366 History of Changes |
| Other Study ID Numbers: | ASP-11-001 |
| Study First Received: | February 29, 2012 |
| Last Updated: | May 11, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Intervertebral Disk Degeneration Spinal Diseases Bone Diseases Musculoskeletal Diseases |
ClinicalTrials.gov processed this record on May 22, 2013